Amgen Inc
AMGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000318154
In the last 90 days, Amgen Inc insiders filed 0 open-market purchases and 1 sale; 3,179 institutions reported holding it in 13F filings for Q2 2026, worth $161.7B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $251.6B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.35M in total
- 1
- 13F holdersQ2 2026, +57 vs. previous quarter
- 3,179
- 13F valueReported value at the end of Q2 2026
- $161.7B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $36.8B
- +10.0% year over year
- Net income, FY2025
- $7.71B
- +88.5% year over year
- Free cash flow, FY2025
- $8.10B
- −22.1% year over year
- Revenue, Q3 FY2026
- $10.4B
- +8.5% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 12.6M
- Shares sold short
- Change
- −785.9K
- −5.9% vs. previous
- Days to cover
- 4.97
- At average daily volume
Superinvestors holding AMGN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding AMGN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Amgen Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)7:05 PM ET | Aug 11-13 | 2 days | Khosla RachnaSVP, Business Development | SSale | −3.25K | $414.05 | −$1.35M | −33.7%6.40K after | 2 lots |
| Aug 7, 2026 (view filing)6:47 PM ET | Aug 6 | 1 day | Miller DerekSVP, Human Resources | SSale | −3.89K | $402.54 | −$1.57M | −23.8%12.5K after | 2 lots |
| Aug 7, 2026 (view filing)6:45 PM ET | Aug 6 | 1 day | Grygiel Nancy A.SVP & CCO | SSale | −2.97K | $402.16 | −$1.19M | −28.8%7.34K after | 2 lots |
| May 5, 2026 (view filing) | May 4 | 1 day | Grygiel Nancy A.SVP & CCO | SSale | −1.24K | $323.73 | −$400.5K | −15.0%7.01K after | |
| Mar 2, 2026 (view filing) | Feb 26 | 4 days | Santos EstebanEVP, Operations | SSale | −54.8K | $379.12 | −$20.8M | −41.7%76.6K after | 2 lots |
| Feb 20, 2026 (view filing) | Feb 19 | 1 day | Busch Matthew C.VP, Finance & CAO | SSale | −1.00K | $375.79 | −$375.8K | −22.6%3.42K after | |
| Nov 21, 2025 (view filing) | Nov 20 | 1 day | Grygiel Nancy A.SVP & CCO | SSale | −3.14K | $337.26 | −$1.06M | −30.3%7.22K after | 2 lots |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Khosla RachnaSVP, Business Development | SSale | −890 | $336.24 | −$299.3K | −11.2%7.08K after | |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Gordon MurdoEVP, Global Commercial Ops | SSale | −6.88K | $336.83 | −$2.32M | −14.1%41.9K after | |
| Aug 22, 2025 (view filing) | Aug 20 | 2 days | Grygiel Nancy A.SVP & CCO | SSale | −1.27K | $296.99 | −$376.3K | −14.9%7.21K after |
Top 10 13F holders, Q2 2026
See all 3,179 holdersThe largest institutional positions in Amgen Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49,362,016 | $17.9B | 0.27% | +2,261,544+4.8% | Added |
| Vanguard Capital Management LLC | 35,250,101 | $12.8B | 0.27% | +235,869+0.7% | Added |
| State Street Corp | 30,560,537 | $11.1B | 0.33% | +12,0490.0% | Added |
| Capital World Investors | 29,075,329 | $10.5B | 1.24% | −213,014−0.7% | Reduced |
| Invesco Ltd. | 16,320,446 | $5.91B | 0.47% | +434,940+2.7% | Added |
| Geode Capital Management, LLC | 15,696,068 | $5.67B | 0.30% | +265,544+1.7% | Added |
| Charles Schwab Investment Management Inc | 15,034,038 | $5.44B | 0.72% | +2,260,652+17.7% | Added |
| Vanguard Portfolio Management LLC | 14,853,366 | $5.38B | 0.24% | +232,218+1.6% | Added |
| Morgan Stanley | 13,653,692 | $4.94B | 0.26% | −2,182,366−13.8% | Reduced |
| Wells Fargo & Company | 7,235,462 | $2.62B | 0.46% | +147,452+2.1% | Added |
Holders of 5% or more of AMGN
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Amgen Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.60%40.8M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 7.51%40.5M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Capital World Investors | 13G | 5.50%29.6M shares | New | May 14, 20261 filing | May 14, 2026 | SEC |
Politician trades
All politician trades in AMGN31 members of Congress reported 95 trades in Amgen Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Oct 1, 2026 |  David J. Taylor House · OH | Buy | $1K-$15K |
| Sep 5, 2026 | David J. Taylor House · OH | Sell | $1K-$15K |
| Sep 5, 2026 | David J. Taylor House · OH | Sell | $1K-$15K |
| Sep 2, 2026 |  Sheldon Whitehouse Senate · RI | Sell (partial) | $1K-$15K |
| Aug 5, 2026 |  Tommy Tuberville Senate · AL | Sell (full) | $15K-$50K |
House · OH · Oct 1, 2026
Buy$1K-$15K
House · OH · Sep 5, 2026
Sell$1K-$15K
House · OH · Sep 5, 2026
Sell$1K-$15K
Senate · RI · Sep 2, 2026
Sell (partial)$1K-$15K
Senate · AL · Aug 5, 2026
Sell (full)$15K-$50K